QM · rank #15 · 2026-09-07
EXENS
PARIS · EUR · $3.32B (USD)
The exact numbers the algorithm saw.
| Momentum 12-1 Return from 12 months ago to 1 month ago. | +60.26% |
|---|---|
| ROE TTM Return on equity, trailing 12 months. | +12.7% |
| Profit margin Net profit margin, trailing 12 months. | +6.0% |
| Market cap (USD) Size filter: > $300M required (USD-equivalent). | $3.32B |
| Anchor (recent) Close on 2026-08-07 | $63.25 |
| Anchor (far) Close on 2025-08-08 | $39.47 |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Exosens is a European optoelectronics group supplying mission-critical amplification, detection, and imaging components to high-tech OEMs and defence-adjacent system integrators across 12 sites in Europe and North America.
Rationale
The 60% trailing momentum aligns with a genuine fundamental re-rating story — post-IPO profitability inflection (net profit up ~10x YoY in H1 2025), 20%+ revenue growth, and improving ROE support the quality leg of the screen rather than pure sentiment drift.
Material risks
- 1Rapid displacement of incumbent amplification architectures by low-light CMOS and solid-state photodetectors could structurally erode Exosens' core technology moat, the very foundation of its pricing power and long-term contract renewals.
- 2Export control tightening or shifts in government/defence capital allocation could abruptly compress order visibility in Exosens' most sensitive end-markets, breaking the revenue growth trajectory that underpins the momentum signal.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.